Clinical Investigation Specialists

Kenosha, Wisconsin 53142

Use our guide to learn which trials are right for you!

We've found
10 trials
at this facility
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Kenosha, WI
Click here to add this to my saved trials
Migraine Clinical Trial
Evaluation of LY2951742 in the Prevention of Episodic Migraine- the EVOLVE-1 Study
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Kenosha, WI
Click here to add this to my saved trials
Endocrinology Clinical Trial
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Status: Enrolling
Updated: 10/22/2012
mi
from
Kenosha, WI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A 24 Week International, Open-Label Trial With a 28 Week Extension to Evaluate the Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects With Type 2 Diabetes on Metformin With or Without Sulfonylurea Therapy
Status: Enrolling, Phase III
Updated: 2/25/2016
mi
from
Kenosha, WI
Click here to add this to my saved trials
Cardiovascular Disease Clinical Trial
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Kenosha, WI
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
Status: Enrolling, Phase III
Updated: 2/25/2016
mi
from
Kenosha, WI
Click here to add this to my saved trials
Cardiovascular Disease Clinical Trial
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Kenosha, WI
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Status: Enrolling, Phase III
Updated: 12/2/2015
mi
from
Kenosha, WI
Click here to add this to my saved trials
Overactive Bladder Clinical Trial
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Status: Enrolling
Updated: 10/31/2012
mi
from
Kenosha, WI
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
Status: Enrolling, Phase III
Updated: 12/23/2015
mi
from
Kenosha, WI
Click here to add this to my saved trials